![Nuclear export of mRNA and action of selinexor. While eIF4E is mainly... | Download Scientific Diagram Nuclear export of mRNA and action of selinexor. While eIF4E is mainly... | Download Scientific Diagram](https://www.researchgate.net/publication/333983243/figure/fig2/AS:962678919028745@1606531948721/Nuclear-export-of-mRNA-and-action-of-selinexor-While-eIF4E-is-mainly-involved-in.png)
Nuclear export of mRNA and action of selinexor. While eIF4E is mainly... | Download Scientific Diagram
![Cancers | Free Full-Text | Novel Non-Immunologic Agents for Relapsed and Refractory Multiple Myeloma: A Review Article | HTML Cancers | Free Full-Text | Novel Non-Immunologic Agents for Relapsed and Refractory Multiple Myeloma: A Review Article | HTML](https://www.mdpi.com/cancers/cancers-13-05210/article_deploy/html/images/cancers-13-05210-g001.png)
Cancers | Free Full-Text | Novel Non-Immunologic Agents for Relapsed and Refractory Multiple Myeloma: A Review Article | HTML
![Integrated safety profile of selinexor in multiple myeloma: experience from 437 patients enrolled in clinical trials | Leukemia Integrated safety profile of selinexor in multiple myeloma: experience from 437 patients enrolled in clinical trials | Leukemia](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41375-020-0756-6/MediaObjects/41375_2020_756_Fig2_HTML.png)
Integrated safety profile of selinexor in multiple myeloma: experience from 437 patients enrolled in clinical trials | Leukemia
![Integrated safety profile of selinexor in multiple myeloma: experience from 437 patients enrolled in clinical trials | Leukemia Integrated safety profile of selinexor in multiple myeloma: experience from 437 patients enrolled in clinical trials | Leukemia](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41375-020-0756-6/MediaObjects/41375_2020_756_Fig1_HTML.png)
Integrated safety profile of selinexor in multiple myeloma: experience from 437 patients enrolled in clinical trials | Leukemia
![Teresa “Masking & Vax-ing” 😷 💉 on Twitter: "#selinexor #STORM trial update, look at continuous dosing for #pentarefractory #ASH18 #mmsm #myeloma https://t.co/8Qv8mhLdiY" / Twitter Teresa “Masking & Vax-ing” 😷 💉 on Twitter: "#selinexor #STORM trial update, look at continuous dosing for #pentarefractory #ASH18 #mmsm #myeloma https://t.co/8Qv8mhLdiY" / Twitter](https://pbs.twimg.com/media/DtgMcO1UwAIpiXP.jpg)
Teresa “Masking & Vax-ing” 😷 💉 on Twitter: "#selinexor #STORM trial update, look at continuous dosing for #pentarefractory #ASH18 #mmsm #myeloma https://t.co/8Qv8mhLdiY" / Twitter
![XPO1-dependent nuclear export as a target for cancer therapy | Journal of Hematology & Oncology | Full Text XPO1-dependent nuclear export as a target for cancer therapy | Journal of Hematology & Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13045-020-00903-4/MediaObjects/13045_2020_903_Fig1_HTML.png)
XPO1-dependent nuclear export as a target for cancer therapy | Journal of Hematology & Oncology | Full Text
![Introductory Chapter: Oral Selinexor, a Selective Inhibitor of Nuclear Export in the Treatment of Patients with Multiple Myeloma Refractory to Proteasome Inhibitors, Immunomodulatory Agents and Monoclonal Antibodies | IntechOpen Introductory Chapter: Oral Selinexor, a Selective Inhibitor of Nuclear Export in the Treatment of Patients with Multiple Myeloma Refractory to Proteasome Inhibitors, Immunomodulatory Agents and Monoclonal Antibodies | IntechOpen](https://www.intechopen.com/media/chapter/75812/media/F1.png)
Introductory Chapter: Oral Selinexor, a Selective Inhibitor of Nuclear Export in the Treatment of Patients with Multiple Myeloma Refractory to Proteasome Inhibitors, Immunomodulatory Agents and Monoclonal Antibodies | IntechOpen
![Rafael Fonseca MD 🇺🇸🏜🇲🇽 on Twitter: "Selinexor is Rookie#2. Data on Ph2 STORM (+dex) study. Quad/penta ref MM. ORR 21% VGPR5% DOR 5mos Some GI tox @akeithstewart #ASH16… https://t.co/J9jTn433C2" Rafael Fonseca MD 🇺🇸🏜🇲🇽 on Twitter: "Selinexor is Rookie#2. Data on Ph2 STORM (+dex) study. Quad/penta ref MM. ORR 21% VGPR5% DOR 5mos Some GI tox @akeithstewart #ASH16… https://t.co/J9jTn433C2"](https://pbs.twimg.com/media/Cy4Ga_YUcAA8pdv.jpg:large)
Rafael Fonseca MD 🇺🇸🏜🇲🇽 on Twitter: "Selinexor is Rookie#2. Data on Ph2 STORM (+dex) study. Quad/penta ref MM. ORR 21% VGPR5% DOR 5mos Some GI tox @akeithstewart #ASH16… https://t.co/J9jTn433C2"
![Chemical structure, mechanism of action, and important molecules with... | Download Scientific Diagram Chemical structure, mechanism of action, and important molecules with... | Download Scientific Diagram](https://www.researchgate.net/publication/328349118/figure/fig1/AS:682891184992258@1539825354200/Chemical-structure-mechanism-of-action-and-important-molecules-with-XPO-1-relatedness.png)